The Michigan Newborn Screening Quality Assurance Advisory Committee approved the addition of Severe Combined Immunodeficiency Disorder (SCID) to the Michigan newborn screening panel. The Michigan NBS Laboratory began testing for SCID October 1, 2011.
SCID represents a group of more than 13 inherited disorders that lack functional T and B cells responsible for cellular and humoral immunity, respectively. Newborns with SCID are unable to mount an immune response to infection by viruses, bacteria and fungi. They become severely ill during the first year of life and rarely survive beyond the second year. However, if detected early by newborn screening, infants with SCID can be successfully treated by bone marrow transplantation.
Newborn Screening News - Summer 2011
Quick Links
Additional Information
Primary Immunodeficiency Resource Center
Immune Deficiency Foundation
SCID.net
Printer Friendly
Text Version
Twitter
Facebook
Yahoo
Google
Digg
Newsvine
StumbleUpon
Bookmark
Email Page
